1-9 of 9
Eva-Maria Autzinger, MD
Close
Sort by
Journal Articles

Azacitidine in Acute Myeloid Leukemia with >30% Bone Marrow Blasts and <15 G/L White Blood Cell Count: Results from the Austrian Azacitidine Registry of the AGMT Study Group Versus Randomized Controlled Phase III Clinical Trial Data

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Heinz Sill, MD, Konstantin Schlick, MD, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Armin Zebisch, MD, Angelika Pichler, MD, Michael Pfeilstöcker, MD, Eva-Maria Autzinger, MD, Alois Lang, MD, Klaus Geissler, MD, Daniela Voskova, MD, Dietmar Geissler, MD, Wolfgang R Sperr, MD, Sabine Hojas, MD, Inga Mandac Rogulj, MD, Johannes Andel, MD, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 2515.
https://doi.org/10.1182/blood.V126.23.2515.2515
Published: 2015
Journal Articles

Is It Time to Redefine Response in Elderly Patients with WHO-Acute Myeloid Leukemia (AML) Unfit for Intensive Chemotherapy?

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Heinz Sill, MD, Konstantin Schlick, MD, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Armin Zebisch, MD, Angelika Pichler, MD, Michael Pfeilstöcker, MD, Eva-Maria Autzinger, MD, Alois Lang, MD, Klaus Geissler, MD, Daniela Voskova, MD, Dietmar Geissler, MD, Wolfgang R Sperr, MD, Sabine Hojas, MD, Inga Mandac Rogulj, MD, Johannes Andel, MD, Richard Greil, MD
Journal: Blood
Blood (2015) 126 (23): 3742.
https://doi.org/10.1182/blood.V126.23.3742.3742
Published: 2015
Journal Articles

Lenalidomide and Dexamethasone for Acute Light Chain-Induced Renal Failure: Final Results of a Phase II Study

Heinz Ludwig, Univ. Prof. Dr., Elisabeth Rauch, Thomas Kuehr, MD, Adam Zdenek, MD, Adalbert Weissmann, MD, Hedwig Kasparu, MD, Eva-Maria Autzinger, MD, Daniel Heintel, MD, Richard Greil, MD, Wolfram Poenisch, MD, Niklas Zojer, MD, Ercan Müldür, MD
Journal: Blood
Blood (2014) 124 (21): 3484.
https://doi.org/10.1182/blood.V124.21.3484.3484
Published: 2014
Journal Articles

Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 943.
https://doi.org/10.1182/blood.V124.21.943.943
Published: 2014
Journal Articles

Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 2284.
https://doi.org/10.1182/blood.V124.21.2284.2284
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 955.
https://doi.org/10.1182/blood.V124.21.955.955
Published: 2014
Journal Articles

Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3683.
https://doi.org/10.1182/blood.V124.21.3683.3683
Published: 2014
Journal Articles

Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry

Lisa Pleyer, MD DI, Sonja Burgstaller, MD, Reinhard Stauder, MD MSc, Michael Girschikofsky, MD, Werner Linkesch, Univ. Prof, MD, Michael Pfeilstöcker, MD, Eva Maria Autzinger, MD, Christoph Tinchon, MD, Thamer Sliwa, MD, Alois Lang, MD, Wolfgang R. Sperr, MD, Dietmar Geissler, Dr, Prof., Peter Krippl, MD, Daniela Voskova, Dr, MD, Dieter H. Rossmann, MD, Konstantin Schlick, Dr, Josef Thaler, MD, Britta Halter, MSc, Sigrid Machherndl-Spandl, MD, Georg Theiler, MD, Peter Valent, MD, Otto Eckmüllner, Dr, Richard Greil, MD
Journal: Blood
Blood (2014) 124 (21): 3681.
https://doi.org/10.1182/blood.V124.21.3681.3681
Published: 2014
Journal Articles

Bortezomib-Doxorubicin-Dexamethasone (BDD) in Patients with Acute Light Chain Induced Renal Failure (ARF) in Multiple Myeloma (MM). Final Results of a Phase II Study.

Heinz Ludwig, MD, Zdenek Adam, MD, Roman Hajek, MD, Richard Greil, MD, Elena Tóthová, MD, Felix Keil, MD, Eva-Maria Autzinger, MD, Josef Thaler, MD, Heinz Gisslinger, MD, Alois Lang, MD, Miklós Egyed, MD, PhD, Niklas Zojer, MD
Journal: Blood
Blood (2009) 114 (22): 3862.
https://doi.org/10.1182/blood.V114.22.3862.3862
Published: 2009